The Potency of a KRAS Silent Variant

The overrepresentation of a silent variant in KRAS led investigators to explore whether this mutation was biologically relevant (it was) and could be exploited in a mouse model to treat KRAS-mutant cancer.

Bibliographische Detailangaben

Veröffentlicht in:	The New England journal of medicine 2022-06, Vol.386 (26), p.2523-2525
Hauptverfasser:	Molina-Arcas, Miriam, Downward, Julian
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer Genetics Genetics General Hematology K-Ras protein Kinases Lung cancer Mutation Oncology Oncology General Proteins Treatments in Oncology Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!